aspect of
placebo)
→
HasProperty
→
reversible
| Typicality: | 0.534 |
| Saliency: | 0.437 |
| from the last abiraterone acetate administration | 6 | temporal |
| after 16 weeks | 2 | temporal |
| effect → be → reversible | 9 |
| negative | neutral | positive |
| 0.072 | 0.783 | 0.145 |
| Raw frequency | 9 |
| Normalized frequency | 0.437 |
| Modifier score | 0.800 |
| Perplexity | 241.244 |